Theralase Technologies Inc.
TLT.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 21.28% | -41.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.28% | -41.11% | |||
| Cost of Revenue | 12.83% | 611.59% | |||
| Gross Profit | 30.02% | -70.17% | |||
| SG&A Expenses | 13.14% | -7.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.36% | 26.94% | |||
| Operating Income | -1.04% | -49.18% | |||
| Income Before Tax | -0.81% | -50.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.81% | -50.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.81% | -50.85% | |||
| EBIT | -1.04% | -49.18% | |||
| EBITDA | -1.99% | -54.99% | |||
| EPS Basic | 7.14% | -47.37% | |||
| Normalized Basic EPS | 5.88% | -41.67% | |||
| EPS Diluted | 7.14% | -47.37% | |||
| Normalized Diluted EPS | 5.88% | -41.67% | |||
| Average Basic Shares Outstanding | 7.08% | 1.75% | |||
| Average Diluted Shares Outstanding | 7.08% | 1.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||